BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11687642)

  • 1. Expression of cyclins E1 and E2 during mouse development and in neoplasia.
    Geng Y; Yu Q; Whoriskey W; Dick F; Tsai KY; Ford HL; Biswas DK; Pardee AB; Amati B; Jacks T; Richardson A; Dyson N; Sicinski P
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13138-43. PubMed ID: 11687642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement for cyclin E in c-Myc overexpressing breast cancers.
    Zhou Y; Geng Y; Zhang Y; Zhou Y; Chu C; Sharma S; Fassl A; Butter D; Sicinski P
    Cell Cycle; 2020 Oct; 19(20):2589-2599. PubMed ID: 32975478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
    Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
    Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
    Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
    Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
    Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
    Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation.
    White J; Stead E; Faast R; Conn S; Cartwright P; Dalton S
    Mol Biol Cell; 2005 Apr; 16(4):2018-27. PubMed ID: 15703208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo.
    Odajima J; Saini S; Jung P; Ndassa-Colday Y; Ficaro S; Geng Y; Marco E; Michowski W; Wang YE; DeCaprio JA; Litovchick L; Marto J; Sicinski P
    PLoS Genet; 2016 Nov; 12(11):e1006429. PubMed ID: 27828963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian cell cycles without cyclin E-CDK2.
    Yu Q; Sicinski P
    Cell Cycle; 2004 Mar; 3(3):292-5. PubMed ID: 14726682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
    Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
    Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase-independent function of E-type cyclins in liver cancer.
    Geng Y; Michowski W; Chick JM; Wang YE; Jecrois ME; Sweeney KE; Liu L; Han RC; Ke N; Zagozdzon A; Sicinska E; Bronson RT; Gygi SP; Sicinski P
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1015-1020. PubMed ID: 29339491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
    Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
    Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors.
    Payton M; Scully S; Chung G; Coats S
    Oncogene; 2002 Dec; 21(55):8529-34. PubMed ID: 12466974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.
    Caldon CE; Sergio CM; Kang J; Muthukaruppan A; Boersma MN; Stone A; Barraclough J; Lee CS; Black MA; Miller LD; Gee JM; Nicholson RI; Sutherland RL; Print CG; Musgrove EA
    Mol Cancer Ther; 2012 Jul; 11(7):1488-99. PubMed ID: 22564725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
    Zariwala M; Liu J; Xiong Y
    Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.